Choose date and time: ×
In the last 2 hours
In the last 4 hours
In the last 6 hours
In the last 8 hours
Trinity Biotech gives bonuses despite slump The Irish Independent 02:36
Argenx IPO: A Biotech Turnaround? Seeking Alpha 21:41 25-Apr-17
3 Things You Didn't Know About bluebird bio, Inc. The Motley Fool 21:34 25-Apr-17
Biogen: Key Q1 2017 Insights Seeking Alpha 21:06 25-Apr-17
CCI orders probe against Roche 21:04 25-Apr-17
Tesaro Inc Bulls Need a Reality Check The Motley Fool 20:44 25-Apr-17
MannKind May Not Go Bankrupt, But... Seeking Alpha 20:25 25-Apr-17
US FDA warns Lonza about Walkersville site Biopharma Reporter 19:03 25-Apr-17
Fresenius Kabi to buy Merck KGaA biosimilar candidates Biopharma Reporter 19:03 25-Apr-17
Gilead Sciences: NASH Bridges…To What? Barron's Online 18:50 25-Apr-17
Biogen Jumps On Q1 Results: Analysis Seeking Alpha 17:54 25-Apr-17
CCI orders detailed probe against pharma major Roche The Times of India 17:33 25-Apr-17
Synergy Pharmaceuticals: Where To Next? Seeking Alpha 17:14 25-Apr-17
World Earth Day And Nigeria’s Stand For Science Leadership, Nigeria 16:08 25-Apr-17
Neuroderm: A Top Momentum Biotech For 2017 Seeking Alpha 15:34 25-Apr-17
Terrific Tuesday - Markets Go Through The Roof Seeking Alpha 15:13 25-Apr-17
Artificial Womb Sets Record for Keeping Fetuses Alive MIT Technology Review 15:08 25-Apr-17
MannKind Corporation Needs A Merger Seeking Alpha 13:52 25-Apr-17
Why Achillion Pharmaceuticals Stock Sank on Monday The Motley Fool 13:40 25-Apr-17
Forge Therapeutics scores $15 million in venture funding Chemical & Engineering News 13:10 25-Apr-17
BPI Europe 2017: Biomanufacturing industry goes Dutch Biopharma Reporter 10:00 25-Apr-17
Jubilant Life gets USFDA nod for hypertension drug The Times of India 08:30 25-Apr-17
Availability, accessibility key to affordable drugs The Times of India 08:30 25-Apr-17
Biocon to consider bonus issue; stock northbound India Info Line 05:17 25-Apr-17
Will We Ever Get a Better Male Contraceptive? MIT Technology Review 05:05 25-Apr-17
Girls outshine boys in Plus III exam of Utkal University The New Indian Express 01:58 25-Apr-17
No stent can be withdrawn for now: Centre The Times of India 01:36 25-Apr-17
In the last 7 days
BioMarin sees 'high end' pricing on Brineura FiercePharma 23:00 24-Apr-17
Pharma companies discuss order on generic drugs The Times of India 21:19 24-Apr-17
Can Synergy Pharmaceuticals Succeed On Its Own? Seeking Alpha 20:31 24-Apr-17
IHI: Keep Riding The Medical Devices Momentum Seeking Alpha 18:40 24-Apr-17
Better Buy: Gilead Sciences vs. Celgene The Motley Fool 18:30 24-Apr-17
FIPB refers Gland Pharma proposal to CCEA for approval The Times of India 16:41 24-Apr-17
Gilead Sciences: Know Hope…or No Hope? Barron's Online 15:03 24-Apr-17

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • This site uses cookies. To see how, read our Privacy and Cookie Notice. If you disagree with our use of cookies, please navigate away.
Sorry, no headlines or news topics were found. Please try different keywords.